Atlas Trials

Target Gene Sequencing for Advanced Stage, Relapsed or Refractory Natural Killer/T-cell Lymphoma

Clinical trial NCT04509804 · COMPLETED

Trial details

NCT number
NCT04509804
Sponsor
Chinese Academy of Medical Sciences
Status
COMPLETED
Study type
OBSERVATIONAL
Lymphoid Neoplasm
Start date
2018-05-10
Primary completion
2019-09-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.